Capítulo 13 – Tratamiento de la neovascularización coroidea en el miope magno con inyección intravítrea de antiangiogénicos

Wai-Man Chan, Timothy Y.Y. Lai, David T.L. Liu, Dennis S.C. Lam, Intravitreal Bevacizumab (Avastin) for Myopic Choroidal Neovascularization : Six-Month Results of a Prospective Pilot Study Ophthalmology. ,vol. 114, pp. 2190- 2196 ,(2007) , 10.1016/J.OPHTHA.2007.03.043

Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham, Matthew Feinsod, David R. Guyer, Pegaptanib for Neovascular Age-Related Macular Degeneration The New England Journal of Medicine. ,vol. 351, pp. 2805- 2816 ,(2004) , 10.1056/NEJMOA042760

S. Mandal, P. Venkatesh, R. Sampangi, S. Garg, Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization. European Journal of Ophthalmology. ,vol. 17, pp. 620- 626 ,(2007) , 10.1177/112067210701700422

RICHARD F. SPAIDE, KETAN LAUD, HOWARD F. FINE, JAMES M. KLANCNIK, CATHERINE B. MEYERLE, LAWRENCE A. YANNUZZI, JOHN SORENSON, JASON SLAKTER, YALE L. FISHER, MICHAEL J. COONEY, Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 383- 390 ,(2006) , 10.1097/01.IAE.0000238561.99283.0E

Michael D. Bennett, Wendy Yee, Pegaptanib for myopic choroidal neovascularization in a young patient. Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 245, pp. 903- 905 ,(2007) , 10.1007/S00417-006-0472-6

RUFINO M. SILVA, JOSÉ M. RUIZ-MORENO, JOÃO NASCIMENTO, ÃNGELA CARNEIRO, PAULO ROSA, AUGUSTO BARBOSA, FAUSTO CARVALHEIRA, J RUI FARIA ABREU, JOSÉ G. CUNHA-VAZ, SHORT-TERM EFFICACY AND SAFETY OF INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION Retina. ,vol. 28, pp. 1117- 1123 ,(2008) , 10.1097/IAE.0B013E31817EDA41

ASHEESH TEWARI, MANDEEP S. DHALLA, RAJENDRA S. APTE, Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 1093- 1094 ,(2006) , 10.1097/01.IAE.0000254896.78766.74

RYAN M. RICH, PHILIP J. ROSENFELD, CARMEN A. PULIAFITO, SANDER R. DUBOVY, JANET L. DAVIS, HARRY W. FLYNN, SERAFIN GONZALEZ, WILLIAM J. FEUER, RICHARD C. LIN, GEETA A. LALWANI, JACKIE K. NGUYEN, GAURAV KUMAR, Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 26, pp. 495- 511 ,(2006) , 10.1097/01.IAE.0000225766.75009.3A

WAI-MAN CHAN, TIMOTHY Y.Y. LAI, KWOK-PING CHAN, HAITAO LI, DAVID T.L. LIU, DENNIS S.C. LAM, CHI-PUI PANG, Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 28, pp. 1308- 1313 ,(2008) , 10.1097/IAE.0B013E31818358B2

J M Ruiz-Moreno, J A Montero, F Gomez-Ulla, S Ares, Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome British Journal of Ophthalmology. ,vol. 93, pp. 448- 451 ,(2009) , 10.1136/BJO.2008.145391